Globally, men live an average of five years fewer than women and largely for preventable reasons. Men are less likely to seek help, less likely to be screened, and less likely to receive treatment. That gap is not inevitable.
Androlabs is the first global pharmaceutical company dedicated to men’s health. Our current therapy areas include testosterone deficiency and erectile dysfunction. Alongside our products, we support healthcare professionals with educational and practical resources to better patient care and increase men’s health knowledge.
Androlabs operates across 20+ countries throughout Europe, the UK, Australia, and the Middle East, with a direct commercial team in the UK, Germany, Italy, and Spain. We are part of Tithonia Group.
